SUPRIYA LIFESCIENCE Q2 FY27 ; STANDALONE

NET PROFIT DOWN 42% AT ₹29 CR (YOY), UP 22% (QOQ) REVENUE UP 3% AT ₹206 CR (YOY), UP 9% (QOQ) EBITDA DOWN 38% AT ₹45 CR (YOY), DOWN 4% (QOQ) MARGINS AT 22.0% VS 36.4% (YOY), 25.0% (QOQ)

SUPRIYA LIFESCIENCE LTD

← Back to feed